Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Targeted Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 600
Not applicableStudy completedNCT05032092
What this trial is testing

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer

Who this might be right for
Locally Advanced CarcinomaMetastatic Cancer
Medical University of Graz 235
Testing effectiveness (Phase 2)Study completedNCT01254864
What this trial is testing

Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 190
Not applicableUnknownNCT05278195
What this trial is testing

Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT05048901
What this trial is testing

Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors,Gastroenteropancreatic
National Health Research Institutes, Taiwan 49
Not applicableStudy completedNCT05332496
What this trial is testing

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 941
Not applicableLooking for participantsNCT05885009
What this trial is testing

Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)

Who this might be right for
Metastatic Prostate Cancer
SOLTI Breast Cancer Research Group 240
Testing effectiveness (Phase 2)Looking for participantsNCT02925234
What this trial is testing

The Drug Rediscovery Protocol (DRUP Trial)

Who this might be right for
CancerTumorsNeoplasm+1 more
The Netherlands Cancer Institute 1,550
Not applicableLooking for participantsNCT07058454
What this trial is testing

Multicenter Prospective Observational Study of Cardiotoxicity in Patients Receiving Targeted Cancer Therapies

Who this might be right for
Cancer;Cardiovascular;Adverse EventsCancer
Sixth Affiliated Hospital, Sun Yat-sen University 5,000
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07822347
What this trial is testing

Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related Tumors

Who this might be right for
Tumor
Peking Union Medical College Hospital 20
Not applicableUnknownNCT04331912
What this trial is testing

PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 100
Not applicableStudy completedNCT00897702
What this trial is testing

Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 269
Not applicableStudy completedNCT04450602
What this trial is testing

A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss

Who this might be right for
Androgenetic AlopeciaAndrogenic AlopeciaTelogen Effluvium+3 more
Arbor Life Labs 46
Testing effectiveness (Phase 2)UnknownNCT03768375
What this trial is testing

Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctGallbladder Cancer
Shanghai Jiao Tong University School of Medicine 150
Not applicableStudy completedNCT05332821
What this trial is testing

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 1,244
Testing effectiveness (Phase 2)Study completedNCT01453257
What this trial is testing

Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients

Who this might be right for
Progression Free Survival
Grupo Hospital de Madrid 72
Not applicableTemporarily pausedNCT04025515
What this trial is testing

Molecular Profiling Project

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
National Cancer Centre, Singapore 500
Testing effectiveness (Phase 2)Looking for participantsNCT05564377
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Who this might be right for
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+12 more
National Cancer Institute (NCI) 2,900
Early research (Phase 1)Study completedNCT02497235
What this trial is testing

Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935

Who this might be right for
Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents
Takeda 11
Not applicableLooking for participantsNCT07649629
What this trial is testing

Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway

Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)
Regina Elena Cancer Institute 70
Next Page